Status:
WITHDRAWN
Sentinel - Triaging Acute Breathlessness Using Multi-Modal Biomarkers
Lead Sponsor:
Sanome
Conditions:
Breathlessness
COPD
Eligibility:
All Genders
18-90 years
Brief Summary
The Sentinel-001 study aims to identify a combination of biomarkers suitable for triage of breathlessness.
Eligibility Criteria
Inclusion
- Aged 18-90 years.
- Has experienced episode of breathlessness during the past 12 months triggering interaction with a health care professional. Self-reported breathlessness using any of the following words to describe symptoms will qualify as a presentation of breathlessness regardless of aetiology or severity of symptoms: shortness of breath, tight chest, trouble breathing, breathlessness, dyspnoeic, breathless, asthmatic, suffocating, wheezing, fighting for breath or any equivalent word. Breathlessness does not have to be the primary presenting symptom.
- Deemed clinically sufficiently stable to participate according to health care practitioner.
Exclusion
- Inability to understand written local language at a year 5 level.
- Not being confident in use of digital technology (smartphone and/or tablet). This will become evident through an inability to use the system.
- Inability to enter required study sample data due to diminished consciousness and/or physical or mental capacity regardless of whether this is associated with the breathlessness event.
- Received an investigational medical product in the context of a Clinical Trial during the 28 days prior to first probe administration.
Key Trial Info
Start Date :
March 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2024
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT05304494
Start Date
March 1 2022
End Date
March 1 2024
Last Update
May 13 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.